Tests better diagnosis and treatment planning for kidney disease in type 2 diabetes
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial focuses on improving how kidney damage is diagnosed and how treatment is planned for people with type 2 diabetes and kidney disease. It may help by using detailed medical history and (if done) kidney biopsy results to guide care more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have type 2 diabetes
- Your medical records and clinical test data are complete enough to review
- If you had a kidney biopsy for your kidney disease, the biopsy results must clearly show the diagnosis
- You agree to join and sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with type 2 diabetes who have kidney problems and relates their symptoms and lab findings to what is seen on kidney biopsy. It may help doctors better understand what is driving kidney damage in diabetes.
This study looks at how common diabetic kidney damage is in people with type 2 diabetes, and which factors can predict it. If you qualify, you may be asked to have a kidney biopsy to understand what’s happening inside your kidneys.
This study looks at how heart, kidney, and weight problems affect people with type 2 diabetes. It aims to find better ways to treat these related conditions and improve overall health.
This study tests a new smart screening tool that helps doctors in primary care find and manage diabetic kidney disease—a common complication of diabetes. If you join, your care may be better tailored to your needs, which could help protect your kidneys.
This study looks for early warning signs in blood or other samples (using a special lab approach) to detect kidney problems sooner in people with diabetes. It may help patients and clinicians identify kidney risk earlier and follow changes over many years.
This study is testing a new way to find early signs of kidney damage in people with diabetes. The goal is to catch kidney disease (diabetic nephropathy) sooner, so it can be managed more effectively.
Hear when a new Diabetic Nephropathy Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.